Informations générales (source: ClinicalTrials.gov)
Cohorte ANRS CO5 "Cohorte Nationale VIH2" (ANRS CO VIH2)
Observational
ANRS, Emerging Infectious Diseases (Voir sur ClinicalTrials)
janvier 1994
septembre 2022
29 juin 2024
The HIV2 study is an open cohort of prospective, multicentric, national observation. The
main objective is to study HIV-2 infection in adult patients followed in France.
Etablissements
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| AP-HP - Hôpital Antoine Béclère | Francois Boue, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Avicenne | Olivier OB BOUCHAUD, PhD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Bicêtre | Cécile Goujard, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Bichat | Contact (sur clinicalTrials) | ||||
| AP-HP - Hôpital Cochin | Dominique Salmon, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Henri Mondor-Albert Chenevier | Jean-Daniel Lelievre, MD, PhD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Louis Mourier | Emmanuel Mortier, MD | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Saint Antoine | Marie Caroline Meyohas, Pr | Contact (sur clinicalTrials) | |||
| AP-HP - Hôpital Tenon | Pialloux Gilles, Pr | Contact (sur clinicalTrials) | |||
| CENTRE HOSPITALIER SUD FRANCILIEN | Contact (sur clinicalTrials) | ||||
| CH DE VERSAILLES SITE ANDRE MIGNOT | Alix Greder-Belan, MD | Contact (sur clinicalTrials) | |||
| CHI DE CRETEIL | Valérie GARRAIT, MD | Contact (sur clinicalTrials) | |||
| HOPITAL NOVO | Laurent BLUM | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Hospitalier François Quesnay - Mantes la Jolie - France | Ahmed JABBAR | Contact (sur clinicalTrials) | |||
| Centre hospitalier Victor Dupouy - 95100 - Argenteuil - France | Philippe PG GENET, MD | Contact (sur clinicalTrials) | |||
| CHI Poissy Saint Germain en Laye - 78105 - Saint Germain en Laye - France | Yves Welker, MD | Contact (sur clinicalTrials) | |||
| CHI Villeneuve Saint Georges - 94195 - Villeneuve Saint Georges - France | Olivier Patey, MD | Contact (sur clinicalTrials) | |||
| Hôpital Bretonneau - Service des Maladies Infectieuses - 37044 - Tours - France | Louis Bernard, PH | Contact (sur clinicalTrials) | |||
| Hôpital de La Croix Rousse - Lyon - France | Laurent COTTE | Contact (sur clinicalTrials) | |||
| Hôpital de l'Hotel Dieu - 44093 - Nantes - France | François RAFFI | Contact (sur clinicalTrials) | |||
| Hôpital Delafontaine - 93205 - Saint-Denis - France | Marie-Aude KHUONG | Contact (sur clinicalTrials) | |||
| Hôpital Edouard Herriot - 69437 - Lyon - France | Djamila MAKHLOUFI | Contact (sur clinicalTrials) | |||
| Hôpital Gui de Chaudiac - 34295 - Montpellier - France | Jacques Reynes | Contact (sur clinicalTrials) | |||
| Hôpital Hôtel Dieu - 75181 - Paris - France | Jean-Paul Viard, MD | Contact (sur clinicalTrials) | |||
| Hôpital la Pitié Salpétrière - 75013 - Paris - France | Contact (sur clinicalTrials) | ||||
| Hôpital Lariboisière - 75475 - Paris - France | Agathe Rami, Dr | Contact (sur clinicalTrials) | |||
| Hôpital Pontchaillou - 35033 - Rennes - France | Cedric Arvieux, Dr | Contact (sur clinicalTrials) | |||
| Hôpital Saint André - 33076 - Bordeaux - France | Philippe Morlat, Pr | Contact (sur clinicalTrials) | |||
| Hôpital Saint Louis - 75010 - Paris - France | Jean-Michel Molina, Pr | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- HIV-2 infection only, diagnosed by ELISA, confirmed by Western-Blot test,
- Follow-up in consultation or hospitalization in one of the investigating centers,
- Age greater than or equal to 18 years,
- Prolonged follow-up possible, residence in France planned for at least one year,
- Consent to participate,
- Long-term medical care possible for the participant, or by medical aid (AME), or
declaration of obtaining AME at the time of inclusion.
- HIV-2 infection only, diagnosed by ELISA, confirmed by Western-Blot test,
- Follow-up in consultation or hospitalization in one of the investigating centers,
- Age greater than or equal to 18 years,
- Prolonged follow-up possible, residence in France planned for at least one year,
- Consent to participate,
- Long-term medical care possible for the participant, or by medical aid (AME), or
declaration of obtaining AME at the time of inclusion.
- HIV-1 infection
- Double HIV-1 + HIV-2 seropositivity